Oramed Pharmaceuticals Inc.
ORMP · NASDAQ
6/30/2025 | 3/31/2025 | 12/31/2024 | 9/30/2024 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | $13 | -$8 | -$10 | -$20 |
| Dep. & Amort. | $0 | $0 | $0 | $0 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $1 | $2 | $1 | $0 |
| Change in WC | -$3 | -$2 | $0 | $2 |
| Other Non-Cash | -$15 | $3 | $7 | $11 |
| Operating Cash Flow | -$4 | -$4 | -$2 | -$7 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$0 | -$0 | -$0 | -$0 |
| Net Acquisitions | $0 | -$7 | $0 | $0 |
| Inv. Purchases | -$64 | $0 | -$12 | -$40 |
| Inv. Sales/Matur. | $9 | $29 | $28 | -$82 |
| Other Inv. Act. | -$0 | $2 | -$0 | $88 |
| Investing Cash Flow | -$55 | $24 | $15 | -$34 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $49 | $0 |
| Stock Issued | $0 | $0 | $0 | $0 |
| Stock Repurch. | -$0 | $0 | -$1 | -$1 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $0 | $0 | -$49 | $0 |
| Financing Cash Flow | -$0 | $0 | -$1 | -$1 |
| Forex Effect | $0 | -$0 | -$0 | $0 |
| Net Chg. in Cash | -$59 | $20 | $12 | -$43 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $75 | $54 | $42 | $85 |
| End Cash | $16 | $75 | $54 | $42 |
| Free Cash Flow | -$4 | -$4 | -$2 | -$7 |